{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:00:23Z","timestamp":1790193623414,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/501100021671","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 011954"],"award-info":[{"award-number":["ZIA BC 011954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 010888"],"award-info":[{"award-number":["ZIA BC 010888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kaposi sarcoma-associated herpesvirus (KSHV) causes several diseases among people with HIV (PWH), including Kaposi sarcoma (KS), multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and KSHV inflammatory cytokine syndrome (KICS), known as KSHV-associated diseases (KAD). Genetic diversity in the viral K1 gene defines KSHV subtypes, but clinical significance remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study of 143 PWH with KAD treated between 2004 and 2024. KSHV-DNA was extracted from various clinical samples and sequenced using next-generation and Sanger methods. Phylogenetic analysis was performed to classify K1 subtypes; associations with KAD presentation and survival were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 143 patients, 40% had KS alone, 12% had MCD and KS, 17% had KICS and KS, and 31% had PEL with or without MCD with or without KS. Subtype A was the most prevalent (46%), followed by C (27%); subtypes did not vary by KAD presentations. Patients with concurrent KAD had worse survival than those with KS alone, irrespective of KSHV subtype. Twenty-one patients with PEL and subtype A had poorer survival outcomes as compared with PEL with other subtypes (median overall survival 1.6 vs 7.2 years, P = .0041). Apart from a trend toward lower albumin levels, there were no other differences in clinical characteristics in patients with PEL and subtype A versus other subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, K1 subtypes did not vary by KAD diagnosis and did not impact survival. Individuals with PEL had poorer outcomes, and subtype A in PEL was associated with worse survival. Further studies are required to investigate the functional impact of KSHV genetic variation on disease pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>NCT03300830, NCT00006518, NCT00092222, and NCT00099073.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag168","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:48:02Z","timestamp":1773809282000},"page":"e572-e582","source":"Crossref","is-referenced-by-count":1,"title":["Kaposi Sarcoma Herpesvirus (KSHV) Subtypes and Impact on Outcomes in KSHV-Associated Diseases"],"prefix":"10.1093","volume":"234","author":[{"given":"Jose","family":"Mercado Matos","sequence":"first","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-185X","authenticated-orcid":false,"given":"Vickie A","family":"Marshall","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-1397","authenticated-orcid":false,"given":"Elena M","family":"Cornejo Castro","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-9982","authenticated-orcid":false,"given":"Wendell J","family":"Miley","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5953-4064","authenticated-orcid":false,"given":"Nazzarena","family":"Labo","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3449-3141","authenticated-orcid":false,"given":"Romin","family":"Roshan","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ekwede","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaida","family":"Widell","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Agwu","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Namubiru","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Witterholt","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3057-1395","authenticated-orcid":false,"given":"Robert","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5794-7292","authenticated-orcid":false,"given":"Kathryn","family":"Lurain","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-2563","authenticated-orcid":false,"given":"Denise","family":"Whitby","sequence":"additional","affiliation":[{"name":"Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory , Frederick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5709-4675","authenticated-orcid":false,"given":"Ramya","family":"Ramaswami","sequence":"additional","affiliation":[{"name":"HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"2026092314170487700_jiag168-B1","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"2026092314170487700_jiag168-B2","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.183.5.2385","article-title":"Human herpesvirus-8\/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells","volume":"183","author":"Mesri","year":"1996","journal-title":"J Exp Med"},{"key":"2026092314170487700_jiag168-B3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/jvi.70.1.549-558.1996","article-title":"Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae","volume":"70","author":"Moore","year":"1996","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B4","doi-asserted-by":"crossref","first-page":"ofad160","DOI":"10.1093\/ofid\/ofad160","article-title":"High seroprevalence of Kaposi sarcoma-associated herpesvirus in men who have sex with men with HIV in the southern United States","volume":"10","author":"Knights","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026092314170487700_jiag168-B5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2019-01-893339","article-title":"Viral, immunologic, and clinical features of primary effusion lymphoma","volume":"133","author":"Lurain","year":"2019","journal-title":"Blood"},{"key":"2026092314170487700_jiag168-B6","first-page":"53","article-title":"Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities","volume":"149","author":"Cesarman","year":"1996","journal-title":"Am J Pathol"},{"key":"2026092314170487700_jiag168-B7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026092314170487700_jiag168-B8","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","article-title":"Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"122","author":"Polizzotto","year":"2013","journal-title":"Blood"},{"key":"2026092314170487700_jiag168-B9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi's sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2026092314170487700_jiag168-B10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1386-6532(01)00205-0","article-title":"Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism","volume":"23","author":"Zong","year":"2002","journal-title":"J Clin Virol"},{"key":"2026092314170487700_jiag168-B11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fimmu.2012.00401","article-title":"AKTivation of PI3K\/AKT\/mTOR signaling pathway by KSHV","volume":"3","author":"Bhatt","year":"2013","journal-title":"Front Immunol"},{"key":"2026092314170487700_jiag168-B12","doi-asserted-by":"crossref","first-page":"12173","DOI":"10.1128\/JVI.79.19.12173-12184.2005","article-title":"Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome","volume":"79","author":"Lee","year":"2005","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B13","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1128\/JVI.73.5.4156-4170.1999","article-title":"High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations","volume":"73","author":"Zong","year":"1999","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00002030-199907090-00004","article-title":"Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International collaborative Group","volume":"13","author":"Cook","year":"1999","journal-title":"AIDS"},{"key":"2026092314170487700_jiag168-B15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jmv.24644","article-title":"Molecular typing of human herpesvirus 8 among HIV positive in comparison to HIV-negative individuals in Iran","volume":"89","author":"Varmazyar","year":"2017","journal-title":"J Med Virol"},{"key":"2026092314170487700_jiag168-B16","doi-asserted-by":"crossref","first-page":"101489","DOI":"10.1016\/j.coviro.2025.101489","article-title":"Sequence variability of the K1 gene in Kaposi's sarcoma-associated herpesvirus and its role in pathogenesis","volume":"73","author":"Choi","year":"2025","journal-title":"Curr Opin Virol"},{"key":"2026092314170487700_jiag168-B17","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/jiaa180","article-title":"New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies","volume":"222","author":"Jary","year":"2020","journal-title":"J Infect Dis"},{"key":"2026092314170487700_jiag168-B18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/315456","article-title":"Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype","volume":"181","author":"Biggar","year":"2000","journal-title":"J Infect Dis"},{"key":"2026092314170487700_jiag168-B19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/v13020175","article-title":"Epidemiology and genetic variability of HHV-8\/KSHV among rural populations and Kaposi's sarcoma patients in Gabon, Central Africa. Review of the geographical distribution of HHV-8 K1 genotypes in Africa","volume":"13","author":"Mamimandjiami","year":"2021","journal-title":"Viruses"},{"key":"2026092314170487700_jiag168-B20","doi-asserted-by":"crossref","first-page":"e29654","DOI":"10.1002\/jmv.29654","article-title":"Molecular epidemiology of human herpesvirus 8 in patients with HHV-8-related diseases in Ireland","volume":"96","author":"O'Rourke","year":"2024","journal-title":"J Med Virol"},{"key":"2026092314170487700_jiag168-B21","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1182\/bloodadvances.2023010316","article-title":"Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease","volume":"7","author":"Rasmussen","year":"2023","journal-title":"Blood Adv"},{"key":"2026092314170487700_jiag168-B22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/QAD.0000000000004154","article-title":"Primary effusion lymphoma in people with and without HIV infection in the United States","volume":"39","author":"Volesky-Avellaneda","year":"2025","journal-title":"AIDS"},{"key":"2026092314170487700_jiag168-B23","doi-asserted-by":"crossref","first-page":"e70467","DOI":"10.1002\/jmv.70467","article-title":"Kaposi sarcoma-associated herpesvirus sequencing in people living with HIV in the southern United States reveals subtype diversity and multiple infections","volume":"97","author":"Marshall","year":"2025","journal-title":"J Med Virol"},{"key":"2026092314170487700_jiag168-B24","doi-asserted-by":"crossref","first-page":"e1012338","DOI":"10.1371\/journal.ppat.1012338","article-title":"Sequencing of Kaposi's sarcoma herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance","volume":"20","author":"Marshall","year":"2024","journal-title":"PLoS Pathog"},{"key":"2026092314170487700_jiag168-B25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.10190","article-title":"Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain","volume":"98","author":"de Sanjose","year":"2002","journal-title":"Int J Cancer"},{"key":"2026092314170487700_jiag168-B26","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2026092314170487700_jiag168-B27","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"2026092314170487700_jiag168-B28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"key":"2026092314170487700_jiag168-B29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajh.27580","article-title":"Primary effusion lymphoma prognostic score (PEL-PS): a validated international prognostic score in HIV-associated primary effusion lymphoma","volume":"100","author":"Lurain","year":"2025","journal-title":"Am J Hematol"},{"key":"2026092314170487700_jiag168-B30","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1038\/s41598-021-87038-9","article-title":"Update of the global distribution of human gammaherpesvirus 8 genotypes","volume":"11","author":"Lopes","year":"2021","journal-title":"Sci Rep"},{"key":"2026092314170487700_jiag168-B31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ijc.34136","article-title":"Systematic analysis of Kaposi's sarcoma (KS)-associated herpesvirus genomes from a KS case-control study in Cameroon: evidence of dual infections but no association between viral sequence variation and KS risk","volume":"151","author":"Marshall","year":"2022","journal-title":"Int J Cancer"},{"key":"2026092314170487700_jiag168-B32","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/bloodadvances.2025016685","article-title":"Characteristics and outcomes of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome","volume":"9","author":"Ramaswami","year":"2025","journal-title":"Blood Adv"},{"key":"2026092314170487700_jiag168-B33","doi-asserted-by":"crossref","first-page":"1465.e11","DOI":"10.1016\/j.amjmed.2017.07.020","article-title":"Low albumin levels are associated with mortality risk in hospitalized patients","volume":"130","author":"Akirov","year":"2017","journal-title":"Am J Med"},{"key":"2026092314170487700_jiag168-B34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/1060028020959348","article-title":"Serum albumin levels: who needs them?","volume":"55","author":"Erstad","year":"2021","journal-title":"Ann Pharmacother"},{"key":"2026092314170487700_jiag168-B35","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1128\/JVI.77.14.7978-7990.2003","article-title":"Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis","volume":"77","author":"Akula","year":"2003","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B36","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.77.2.1524-1539.2003","article-title":"Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity","volume":"77","author":"Naranatt","year":"2003","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B37","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1128\/JVI.77.11.6474-6481.2003","article-title":"Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells","volume":"77","author":"Bechtel","year":"2003","journal-title":"J Virol"},{"key":"2026092314170487700_jiag168-B38","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1073\/pnas.96.10.5704","article-title":"Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus","volume":"96","author":"Lagunoff","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026092314170487700_jiag168-B39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nm0498-435","article-title":"Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus","volume":"4","author":"Lee","year":"1998","journal-title":"Nat Med"},{"key":"2026092314170487700_jiag168-B40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jnci\/94.12.926","article-title":"Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene","volume":"94","author":"Prakash","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"2026092314170487700_jiag168-B41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1099\/vir.0.19465-0","article-title":"Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations","volume":"85","author":"Whitby","year":"2004","journal-title":"J Gen Virol"},{"key":"2026092314170487700_jiag168-B42","first-page":"1","article-title":"Modern evolutionary history of the human KSHV genome","volume":"312","author":"Hayward","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"2026092314170487700_jiag168-B43","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/JVI.73.8.6646-6660.1999","article-title":"Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end","volume":"73","author":"Poole","year":"1999","journal-title":"J Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag168\/67385942\/jiag168.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/3\/e572\/67385942\/jiag168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/3\/e572\/67385942\/jiag168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:17:17Z","timestamp":1790187437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/234\/3\/e572\/8527033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,18]]},"published-print":{"date-parts":[[2026,9,23]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag168","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,15]]},"published":{"date-parts":[[2026,3,18]]}}}